OncoTricks

Three lab results that lie, Oct 21, 2026

A lupus anticoagulant drawn on warfarin

A woman with a pulmonary embolism, on warfarin, has a lupus anticoagulant panel sent. The lab writes "no lupus anticoagulant detected, consistent with a deficiency of factors IX, XI, XII". Nobody is deficient. She is on warfarin. The PTT-based test cannot tell which intrinsic factor is low, so the report names all of them.

If you remember one thingWarfarin empties the factors the lupus anticoagulant tests depend on. On warfarin the result is not negative; it is unreadable. The two antibodies can be drawn any time.

Concepts first

WHAT THE WORDS MEAN Antiphospholipid syndrome a clot or a pregnancy loss plus an antibody that persists the antibody targets proteins bound to phospholipid, mainly beta-2-glycoprotein I The three tests BY CLOTTING lupus anticoagulant (LA) BY ELISA, NO CLOTTING anticardiolipin IgG and IgM anti-beta-2-glycoprotein I, IgG and IgM Persistent positive twice, at least 12 weeks apart one positive during an acute clot is a finding, not a diagnosis (Barbhaiya 2023) THE FOUR NAMES ON THE REPORT dRVVT viper venom startsclotting at factor Xneeds X, V, II PTT-LA a PTT built to besensitive to LAneeds XII to II Mixing 1:1 with normal plasmacorrects a deficiency,not an inhibitor Triple positive LA plus bothantibodies: the groupthat stays on warfarin

Why warfarin breaks the test

WARFARIN EMPTIES IIVIIIXX the vitamin K factors THE LA TESTS READ A CLOCK dRVVT PTT-LA both long low X and II stretch the time Mixing step normal plasma refills the barrels, time corrects, "deficiency" is reported Result: unreadable, not negative a true LA can hide under it, and a false positive can appear (Devreese 2020) THE ELISAS HAVE NO CLOCK aCL anti-β2GPI readable antibody sticks or it does not Draw them today warfarin, heparin and the direct oral anticoagulants do not change them

dRVVT dilute Russell viper venom time · PTT-LA partial thromboplastin time with a reagent built to be sensitive to the lupus anticoagulant · aCL anticardiolipin · anti-β2GPI anti-beta-2-glycoprotein I · ELISA enzyme-linked immunosorbent assay: it measures antibody binding, no clotting involved

The direct oral anticoagulants break the test the other way: they prolong the clock without emptying barrels and give false positives.ISTH (the thrombosis society) guidance: do not interpret LA on a direct oral anticoagulant; on warfarin, test only with INR under 1.5. Or use a venom test that skips the vitamin K factors: Taipan snake venom time with ecarin confirmation (Devreese 2020).

Decide in clinic

1. Clot on an anticoagulant, and you want to know about antiphospholipid syndrome?
yes
Draw the two ELISAs nowAnticardiolipin and anti-beta-2-glycoprotein I, IgG and IgM. Titer is the antibody level the ELISA reports: moderate is 40 to 79 units, high is 80 and above (Barbhaiya 2023). Any drug on board is fine.
then
2. Need the lupus anticoagulant itself?
yes
Not on warfarin, not on a direct oral anticoagulantOptions: wait for INR under 1.5, bridging with low-molecular-weight heparin if the clot is recent. Or ask for Taipan snake venom time with ecarin time, which ignores the vitamin K factors. Heparin at therapeutic level also needs a neutralizer in the reagent.
then
3. Anything positive?
yes
Repeat at 12 weeks before you use the word syndromeTransient positives are common around an acute thrombosis and infections. The diagnosis needs the same test positive twice.
then
4. Persistent LA, or triple positive, or an arterial clot?Warfarin, not a direct oral anticoagulant. Rivaroxaban against warfarin in triple-positive patients was stopped early for excess arterial events (TRAPS, Pengo 2018); apixaban met the same fate (ASTRO-APS, Woller 2022). Venous-only disease that is not triple positive: a direct oral anticoagulant may be considered after discussion (Zuily 2020).

Write "lupus anticoagulant not interpretable on warfarin" in the chart. "Negative" will be copied forward for years.

Sources

Retrieved from PubMed, read on Oct 22, 2026.

  1. Devreese KMJ, de Groot PG, de Laat B, et al. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation. J Thromb Haemost 2020. doi:10.1111/jth.15047
  2. Barbhaiya M, Zuily S, Naden R, et al. 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Arthritis Rheumatol 2023. doi:10.1002/art.42624
  3. Pengo V, Denas G, Zoppellaro G, et al. Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. Blood 2018. doi:10.1182/blood-2018-04-848333
  4. Woller SC, Stevens SM, Kaplan D, et al. Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial. Blood Adv 2022. doi:10.1182/bloodadvances.2021005808
  5. Zuily S, Cohen H, Isenberg D, et al. Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: guidance from the Scientific and Standardization Committee of the ISTH. J Thromb Haemost 2020. doi:10.1111/jth.14935

Low counts in cirrhosis: the spleen and the bottle, not the marrow

A man with alcohol-related cirrhosis is referred for "thrombocytopenia and anemia". White cells 2.5, hemoglobin 8, platelets 79 (counts in thousands). He bled in September. He is still drinking. Someone is thinking about a bone marrow.

If you remember one thingIn cirrhosis, three low counts have three ordinary causes: the spleen holds the cells, alcohol stuns the marrow, and the stomach leaks. Hematology's job is to prove the leak and to stop two medicines.

Concepts first

Scarred liver portal vein dammed: pressure backs up Big spleen holds platelets, white and red cells: all three fall Stomach wall dilated vessels ooze: slow, chronic, iron loss less thrombopoietin the liver makes the platelet growth signal Marrow fewer, larger red cells alcohol: direct toxin, plus folate loss; MCV rises Hypersplenismbig spleen, low counts, sound marrow Portal hypertensive gastropathymosaic stomach lining that oozes Varicesdilated veins that bleed fast

Thrombocytopenia is present in about two thirds of cirrhotic patients and is a marker of portal pressure and a failing liver, not of marrow failure.Platelets under 150 in 64% of one cirrhosis series; leukopenia in only 5% (Bashour 2000). The count tracks spleen size and thrombopoietin; shunting the pressure alone restores little, transplantation restores it (Peck-Radosavljevic 2017).

Two ways a cirrhotic stomach bleeds

VaricesDilated veins in the esophagus or stomach. Bleed fast: hematemesis, shock, a transfusion in the emergency room. Treated with banding, octreotide, antibiotics, and then a nonselective beta-blocker to stop the next one.
Portal hypertensive gastropathyThe whole stomach lining oozes from dilated small vessels. Bleeds slowly: black stools on and off, a hemoglobin that keeps sliding, iron deficiency. Nothing to band. Treated with a nonselective beta-blocker, which cut recurrent bleeding in the one randomized trial (65% vs 38% free of rebleeding at 12 months; Pérez-Ayuso 1991), and iron. Refractory: TIPS, a shunt placed through the liver to drop the portal pressure.

The beta-blocker is the treatment for both, and it needs a blood pressure to stand on.Nonselective beta-blockers are first line against recurrent gastropathy bleeding; TIPS when transfusions continue despite them (Baveno VII, de Franchis 2022; Kaplan 2024). Carvedilol is the preferred agent in compensated cirrhosis; start at the lowest tablet. Reduce or stop with systolic under 90 or acute kidney injury (de Franchis 2022).

Decide in clinic

Two prescriptions to stop today1. Oral iron: it turns the stool black and hides the one sign of a slow bleed. Replace iron through the vein.
2. Any NSAID (ibuprofen, naproxen, ketorolac): in cirrhosis it precipitates kidney injury and gastrointestinal bleeding; urgent care prescribes it for back pain without reading the chart. Acetaminophen is the painkiller, with a ceiling of 2 g a day in cirrhosis (NSAID avoidance: Biggins 2021).
1. Big spleen, cirrhosis, all three lines down, MCV (red cell size) high?
yes
Hypersplenism plus alcohol. No marrowSmear, reticulocytes, B12, folate, iron studies, LDH, haptoglobin, INR. Thiamine and folate daily. The counts recover with abstinence and with lower portal pressure.
unless
2. Blasts or dysplastic cells on the smear, a count out of proportion to the spleen, or no recovery after 3 months sober?
yes
Then the marrowMyelodysplasia and alcohol marrow injury look alike on a count; they do not on a biopsy. My working rule, not a guideline: neutrophils under 0.5 or platelets under 30 with a modest spleen also earn the biopsy; leukopenia is rare in hypersplenism alone (Bashour 2000).
then
3. Transferrin saturation (iron in transit) under 20%?
yes
Intravenous ironFerritin is an acute-phase protein and rises in liver disease. The saturation is the honest number here. Two doses of ferumoxytol or five of iron sucrose.
and
4. Needs a procedure with platelets 50 to 100?Count alone does not predict procedural bleeding in cirrhosis; no transfusion for most procedures (Northup 2021). A thrombopoietin agonist (avatrombopag, lusutrombopag) is the option before an elective procedure when the count is under 50 (Terrault 2018).

The patient with a transfusion in September and no beta-blocker in October has an appointment with hepatology, not with hematology. Make it happen this month.

Sources

Retrieved from PubMed, read on Oct 22, 2026.

  1. Peck-Radosavljevic M. Thrombocytopenia in chronic liver disease. Liver Int 2017. doi:10.1111/liv.13317
  2. de Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII: renewing consensus in portal hypertension. J Hepatol 2022. doi:10.1016/j.jhep.2021.12.022
  3. Kaplan DE, Ripoll C, Thiele M, et al. AASLD practice guidance on risk stratification and management of portal hypertension and varices in cirrhosis. Hepatology 2024. doi:10.1097/HEP.0000000000000647
  4. Pérez-Ayuso RM, Piqué JM, Bosch J, et al. Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet 1991. doi:10.1016/0140-6736(91)93125-S
  5. Biggins SW, Angeli P, Garcia-Tsao G, et al. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the AASLD. Hepatology 2021. doi:10.1002/hep.31884
  6. Northup PG, Garcia-Pagan JC, Garcia-Tsao G, et al. Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the AASLD. Hepatology 2021. doi:10.1002/hep.31646
  7. Bashour FN, Teran JC, Mullen KD. Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease. Am J Gastroenterol 2000. doi:10.1111/j.1572-0241.2000.02325.x
  8. Terrault N, Chen YC, Izumi N, et al. Avatrombopag before procedures reduces need for platelet transfusion in patients with chronic liver disease and thrombocytopenia (ADAPT-1 and ADAPT-2). Gastroenterology 2018. doi:10.1053/j.gastro.2018.05.025
  9. Ballard HS. The hematological complications of alcoholism. Alcohol Health Res World 1997;21:42. PMID 15706762.

Three iron traps from one afternoon

Three referrals for "anemia". Each chart had a number that was read wrong: a mean cell volume, a ferritin, and a hemoglobin electrophoresis.

If you remember one thingIron deficiency is read from the transferrin saturation and the cell size, not from the ferritin alone, and not from a kidney.

Concepts first

THE FOUR WORDS Ferritin iron in storagerises with inflammation,liver disease, obesity Saturation iron in transit ontransferrin; falls whenscarce or locked away MCV red cell size. Small isiron or thalassemia,never kidney disease Hepcidin the liver hormone thatlocks iron in cells wheninflamed; oral iron fails ABSOLUTE, FUNCTIONAL, AND THE CUTOFFS Absolute deficiency the store is empty ferritin low, saturation low blood loss, diet, malabsorption: find the hole, then fill the store Functional deficiency the store is locked ferritin high, saturation low inflammation, kidney disease, obesity, heart failure: iron by vein Call it deficiency when saturation under 20%: deficient ferritin under 30: deficient ferritin under 100 if inflamed, obese or in heart failure kidney disease: saturation 30% or less and ferritin 500 or less: give iron (KDIGO)

Trap 1. "Anemia of chronic kidney disease, at goal"

What the chart said79-year-old woman, kidney disease stage 3b, hemoglobin 10.6, labeled anemia of kidney disease, "at goal, will monitor".
What the MCV said78, and small is under 80. Anemia of kidney disease is normocytic: too little erythropoietin makes fewer normal cells, not small ones. A small cell is iron deficiency or thalassemia (Babitt 2012). At 79, on aspirin and a proton pump inhibitor, with constipation and weight loss, it is a bleed until the scopes say otherwise.

A hemoglobin target is for after you know why it is low, not instead of knowing.Erythropoiesis-stimulating agents in kidney disease come after iron repletion and, outside dialysis, only with hemoglobin under 10; the ceiling is 11.5, because the trials that aimed at 13 or higher added stroke and thrombosis (KDIGO 2012). In non-dialysis kidney disease KDIGO accepts a 1 to 3 month oral iron trial; with a proton pump inhibitor, constipation or prior intolerance, go by vein.

Trap 2. Ferritin 695, saturation 5%

SAME TUBE, TWO STORIES 695 ferritin, ng/mL upper normal inflamed, in hospital: pushed up 5% saturation cutoff 20% iron in transit: almost none the marrow starves Verdict functional deficiency on top of blood loss repeat the panel out of hospital, then iron by vein

Ferritin rises with any inflammation; saturation does not lie upward.With inflammation, ferritin under 100 with saturation under 20% defines a deficiency that responds to intravenous iron (Camaschella 2015; Weiss 2019). In kidney disease the KDIGO thresholds in the figure apply. The hepcidin that raises ferritin also blocks the gut, which is why oral iron fails in these patients.

Trap 3. The electrophoresis read while the iron was low

What the lab saidHemoglobin A2 2.3%, "normal, no thalassemia trait", drawn with a ferritin of 5.
What iron deficiency does to A2It lowers it, in proportion to how low the hemoglobin and the cell volume are (Harthoorn-Lasthuizen 1999). A beta-thalassemia carrier (A2 of 3.5% or more) can slip under that cutoff while iron deficient. Replete the iron, then test, or read the result with that in mind.

The woman who stays microcytic after her ferritin is back to normal is the one who needs the electrophoresis.

Bonus. Heavy periods since the first one

Before the hysterectomy, the von Willebrand panelHeavy menstrual bleeding since menarche with recurrent iron deficiency: von Willebrand disease is found in about 1 in 8 women investigated for menorrhagia (Shankar 2004). Normal clotting times (PT, PTT) and a normal platelet count do not exclude it. Send von Willebrand antigen, activity and factor VIII before any surgery (James 2021), and tell the surgeon (ACOG 2019; Connell 2021).

Heavy periods since the first period is a bleeding history, not a gynecology history: send the von Willebrand panel before anyone blames the uterus.

Sources

Retrieved from PubMed, read on Oct 22, 2026.

  1. KDIGO Anemia Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease, chapter 2: use of iron to treat anemia in CKD. Kidney Int Suppl 2012. doi:10.1038/kisup.2012.34
  2. KDIGO Anemia Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease, chapter 3: use of ESAs and other agents to treat anemia in CKD. Kidney Int Suppl 2012. doi:10.1038/kisup.2012.35
  3. Camaschella C. Iron-deficiency anemia. N Engl J Med 2015. doi:10.1056/NEJMra1401038
  4. Camaschella C. Iron deficiency. Blood 2019. doi:10.1182/blood-2018-05-815944
  5. Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood 2019. doi:10.1182/blood-2018-06-856500
  6. Babitt JL, Lin HY. Mechanisms of anemia in CKD. J Am Soc Nephrol 2012. doi:10.1681/ASN.2011111078
  7. Harthoorn-Lasthuizen EJ, Lindemans J, Langenhuijsen MM. Influence of iron deficiency anaemia on haemoglobin A2 levels: possible consequences for beta-thalassaemia screening. Scand J Clin Lab Invest 1999. doi:10.1080/00365519950186011
  8. Shankar M, Lee CA, Sabin CA, Economides DL, Kadir RA. von Willebrand disease in women with menorrhagia: a systematic review. BJOG 2004. doi:10.1111/j.1471-0528.2004.00176.x
  9. ACOG Committee Opinion No. 785: Screening and management of bleeding disorders in adolescents with heavy menstrual bleeding. Obstet Gynecol 2019. doi:10.1097/AOG.0000000000003411
  10. James PD, Connell NT, Ameer B, et al. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Adv 2021. doi:10.1182/bloodadvances.2020003265
  11. Connell NT, Flood VH, Brignardello-Petersen R, et al. ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease. Blood Adv 2021. doi:10.1182/bloodadvances.2020003264